Adherex Technologies, Inc.
Patent protection strengthened for novel approach to cancer therapy
Published in Biotech Law Weekly, October 1st, 2004
The patent covers the use of the company's proprietary cancer therapeutic agents to reduce tumor size and provides broader cancer specific disease protection for its cadherin portfolio.
The compounds work by preventing proteins, known as classical cadherins, from properly acting as the "biological glues" that hold tumor cells together. Cancer cells die through a process known as apoptosis when cell-to-cell binding is inhibited.
"This patent is important to Adherex as it focuses specifically on the core...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2004-10-01)
More Articles from Biotech Law Weekly
- Applied Biosystems Group
Joint venture in mass spectrometry expanded - Business Update
IntegriGuard wins CMS national contract to oversee Medicare's PDDC-TAP - Cell Therapeutics, Inc.
Biotech company adds general counsel, exercises of over-allotment option - Citizens Against Government Waste
Nonpartisan, nonprofit organization offers ideas on health care and trade - Drug Abuse Treatment
Court to hear arguments on who should determine drug, alcohol treatment - Legal Issues
Attorney for family of drug trial suicide victim questions U.S. FDA - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
